SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-001441
Filing Date
2012-01-09
Accepted
2012-01-09 20:27:39
Documents
1
Period of Report
2011-12-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v245088_3.html 3  
1 OWNERSHIP DOCUMENT v245088_3.xml 3 2620
  Complete submission text file 0001144204-12-001441.txt   4430
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019 212-554-4504
Opus Point Partners, LLC (Reporting) CIK: 0001503454 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32639 | Film No.: 12518576